Primary Site >> Colorectal Cancer

Gene >> CAVIN2

Journal: Growth Horm IGF Res. 2009 Oct;19(5):447-56.
Title: Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.
Author: Carroll, Robert E|Goodlad, Robert A|Poole, Aleksandra J|Tyner, Angela L|Robey, R Brooks|Swanson, Steven M|Unterman, Terry G
PMID: 19406679
Journal: Gastroenterology. 2010 Mar;138(3):877-85.
Title: Population-based family history-specific risks for colorectal cancer: a constellation approach.
Author: Taylor, David P|Burt, Randall W|Williams, Marc S|Haug, Peter J|Cannon-Albright, Lisa A
PMID: 19932107
Journal: Tumour Biol. 2016 Jan;37(1):837-45.
Title: Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
Author: Hu, Liang|Chen, Hai-Yang|Han, Tao|Yang, Guang-Zhen|Feng, Dan|Qi, Chen-Ye|Gong, Hui|Zhai, Yan-Xia|Cai, Qing-Ping|Gao, Chun-Fang
PMID: 26254099
Journal: Gastrointest Endosc. 2017 Jun;85(6):1188-1194.
Title: Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry.
Author: Anderson, Joseph C|Butterly, Lynn F|Weiss, Julia E|Robinson, Christina M
PMID: 28153571
Journal: Biochem Pharmacol. 2017 Aug 15;138:185-192.
Title: Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs.
Author: Hara, Akira|Endo, Satoshi|Matsunaga, Toshiyuki|El-Kabbani, Ossama|Miura, Takeshi|Nishinaka, Toru|Terada, Tomoyuki
PMID: 28450226